RBC plans 0% bullish barrier enhanced notes on basket of five stocks

By Wendy Van Sickle

Columbus, Ohio, Oct. 19 – Royal Bank of Canada plans to price 0% bullish barrier enhanced return notes due Oct. 25, 2018 tied to a basket of five equally weighted stocks, according to an FWP filing with the Securities and Exchange Commission.

The basket is comprised of the common stocks of Amgen Inc., Gilead Sciences, Inc., Johnson & Johnson, Merck & Co., Inc. and Pfizer Inc.

The payout at maturity will be par plus 150% of any basket gain, up to a maximum return of 41.25% to 48.75%.

If the basket falls by 25% or less, investors will receive par. If the basket declines by more than 25%, investors will be fully exposed to the loss.

RBC Capital Markets, LLC is the agent.

The notes will price on Oct. 21 and settle on Oct. 26.

The Cusip number is 78012KHX8.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.